APRIL LUST: Open Payments
NPI 1013996222 · SUFFOLK, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$647 in 30 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $523 · 2025 $647
Food & beverage: $647
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $181 |
| Novo Nordisk Inc | 9 | $170 |
| Lilly USA, LLC | 3 | $78 |
| Exact Sciences Corporation | 2 | $58 |
| Collegium Pharmaceutical, Inc. | 2 | $43 |
| Inari Medical, Inc. | 1 | $36 |
| Regeneron Healthcare Solutions, Inc. | 1 | $27 |
| Janssen Pharmaceuticals, Inc | 1 | $24 |
| GlaxoSmithKline, LLC. | 1 | $17 |
| ALK-Abello, Inc | 1 | $15 |
Products named: Wegovy, MOUNJARO, VRAYLAR, QULIPTA, Cologuard Collection Kit, Ozempic, Jornay PM, FLOWTRIEVER CATHETER, S.
Industry payments across VA — which companies pay providers there.
